Manipal Health Enterprises
Manipal Health Enterprises is one of India's largest hospital chains, running a national network of hospitals, clinics and diagnostic centres.
Last updated 6 Aug 2026, 6:12 pm IST
- Price band
- ₹560 – ₹590
- Lot size
- 25
- Issue size
- ₹9,275.22 Cr
- Opens
- 29 Jul 2026
- Closes
- 31 Jul 2026
- Exchange
- Both
The numbers
- GMP
- ₹9 (~2%)
- Subscription
- 4.92× (final)
- Listing gain
- +10.5% (NSE) / +11.0% (BSE)
- Listing date
- 5 Aug 2026
- Model prediction
- Listed 5 Aug: +10.5% NSE / +11.0% BSE. Neutral call — solid double-digit debut, well above the flat read.
The Ticker Tales take
Manipal Health Enterprises is one of India's largest hospital chains — the biggest private multispecialty group by licensed beds — running a national network of hospitals, clinics and diagnostic centres. This was a big ₹9,275 Cr issue (fresh shares plus an offer for sale) at a ₹560–590 band, with a chunk of the fresh money going to pay down debt. Demand picked up late to finish about 4.92× subscribed — a healthy close after a slow start — though the grey-market premium stayed thin at about ₹9 (~2%). Anil Singhvi (Zee Business) posted his IPO review video but didn't state a clear apply/avoid verdict. We stayed Neutral, seeing no real listing edge on the thin premium. It listed on 5 Aug at ₹652 on NSE (+10.5%) and ₹655 on BSE (+11.0%) — a solid double-digit debut, well above the flat read our Neutral call implied, so day-one investors saw a healthy gain.
More details
- Sector
- Hospitals / healthcare
- Issue type
- Fresh issue + Offer for Sale
- Anil Singhvi - Long-term call
- Not clearly stated
- Anil Singhvi - Listing-gain call
- Not clearly stated
Want a heads-up when a new IPO opens?
We'll email you when one opens — and only then.
No spam, ever. Leave whenever you like.
Calls here follow a set formula (GMP, subscription trends) plus Anil Singhvi's publicly shared view — not investment advice. Please do your own research before investing.